SAN DIEGO, CA, Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, announced a $16 million Series A investment.
Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
